The Wisconsin Economic Development Corp. was a partner with Eli Lilly to meet site selection and workforce needs and the two organizations will continue working together, said Missy Hughes ...

“Our work to bolster Wisconsin’s workforce to address our generational ... We have also welcomed major investments from ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

In addition to Wisconsin’s designation as a Tech Hub, Gov. Evers has also worked to secure multi-billion dollar investments ...

Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier this year. The investment in Kenosha County, Wisconsin is aimed at ...

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Eli Lilly said the Food and Drug Administration approved Zepbound ... Earlier this month, Lilly said it planned to invest $3 billion in a Wisconsin manufacturing facility to meet growing demand for ...

With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, ...

Eli Lilly is the maker of high-in-demand injectable ... premier business information and networking series in southeastern Wisconsin. It presents CEOs and other top business headline makers ...

Eli Lilly will spend $3 billion expanding a recently acquired manufacturing facility in Wisconsin to provide capacity for injectable products, including its fast-growing obesity and diabetes drugs.

The S&P 500 added 0.7% on Monday, Dec. 23, 2024, with tech stocks outperforming as the holiday-shortened week got underway.

Eli Lilly's Zepbound defeats Novo Nordisk's Wegovy ... Just last week, the company committed $3 billion to expand the Kenosha, Wisconsin, plant it purchased from Nexus Pharmaceuticals in April ...